• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强效人神经介素U受体1六肽激动剂的发现及其血清代谢物的鉴定。

Discovery of potent hexapeptide agonists to human neuromedin u receptor 1 and identification of their serum metabolites.

作者信息

Takayama Kentaro, Mori Kenji, Sohma Yuko, Taketa Koji, Taguchi Akihiro, Yakushiji Fumika, Minamino Naoto, Miyazato Mikiya, Kangawa Kenji, Hayashi Yoshio

机构信息

Department of Medicinal Chemistry, Tokyo University of Pharmacy and Life Sciences , 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan.

Department of Biochemistry and Department of Molecular Pharmacology, National Cerebral and Cardiovascular Center Research Institute , 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan.

出版信息

ACS Med Chem Lett. 2015 Jan 28;6(3):302-7. doi: 10.1021/ml500494j. eCollection 2015 Mar 12.

DOI:10.1021/ml500494j
PMID:25815150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4360155/
Abstract

Neuromedin U (NMU) and S (NMS) display various physiological activities, including an anorexigenic effect, and share a common C-terminal heptapeptide-amide sequence that is necessary to activate two NMU receptors (NMUR1 and NMUR2). On the basis of this knowledge, we recently developed hexapeptide agonists 2 and 3, which are highly selective to human NMUR1 and NMUR2, respectively. However, the agonists are still less potent than the endogenous ligand, hNMU. Therefore, we performed an additional structure-activity relationship study, which led to the identification of the more potent hexapeptide 5d that exhibits similar NMUR1-agonistic activity as compared to hNMU. Additionally, we studied the stability of synthesized agonists, including 5d, in rat serum, and identified two major biodegradation sites: Phe(2)-Arg(3) and Arg(5)-Asn(6). The latter was more predominantly cleaved than the former. Moreover, substitution with 4-fluorophenylalanine, as in 5d, enhanced the metabolic stability at Phe(2)-Arg(3). These results provide important information to guide the development of practical hNMU agonists.

摘要

神经介素U(NMU)和神经介素S(NMS)具有多种生理活性,包括厌食作用,并且共享一个共同的C末端七肽酰胺序列,该序列是激活两种NMU受体(NMUR1和NMUR2)所必需的。基于这一认识,我们最近开发了六肽激动剂2和3,它们分别对人NMUR1和NMUR2具有高度选择性。然而,这些激动剂的效力仍低于内源性配体hNMU。因此,我们进行了一项额外的构效关系研究,从而鉴定出了效力更强的六肽5d,其表现出与hNMU相似的NMUR1激动活性。此外,我们研究了包括5d在内的合成激动剂在大鼠血清中的稳定性,并确定了两个主要的生物降解位点:苯丙氨酸(2)-精氨酸(3)和精氨酸(5)-天冬酰胺(6)。后者比前者更易被切割。此外,如果像在5d中那样用4-氟苯丙氨酸进行取代,则会增强苯丙氨酸(2)-精氨酸(3)处的代谢稳定性。这些结果为指导实用的hNMU激动剂的开发提供了重要信息。

相似文献

1
Discovery of potent hexapeptide agonists to human neuromedin u receptor 1 and identification of their serum metabolites.强效人神经介素U受体1六肽激动剂的发现及其血清代谢物的鉴定。
ACS Med Chem Lett. 2015 Jan 28;6(3):302-7. doi: 10.1021/ml500494j. eCollection 2015 Mar 12.
2
Discovery of selective hexapeptide agonists to human neuromedin U receptors types 1 and 2.发现选择性六肽激动剂对人类孤啡肽 U 受体 1 型和 2 型。
J Med Chem. 2014 Aug 14;57(15):6583-93. doi: 10.1021/jm500599s. Epub 2014 Jul 18.
3
Discovery of a Human Neuromedin U Receptor 1-Selective Hexapeptide Agonist with Enhanced Serum Stability.发现一种具有增强血清稳定性的人神经钙素 U 受体 1 选择性六肽激动剂。
J Med Chem. 2017 Jun 22;60(12):5228-5234. doi: 10.1021/acs.jmedchem.7b00694. Epub 2017 Jun 2.
4
The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2).中枢给予神经介素U和神经介素S的抗肥胖作用主要由神经介素U受体2(NMUR2)介导。
Endocrinology. 2009 Jul;150(7):3101-9. doi: 10.1210/en.2008-1772. Epub 2009 Mar 26.
5
Characterization of neuromedin U (NMU), neuromedin S (NMS) and their receptors (NMUR1, NMUR2) in chickens.鸡中神经调节素 U(NMU)、神经调节素 S(NMS)及其受体(NMUR1、NMUR2)的特性。
Peptides. 2018 Mar;101:69-81. doi: 10.1016/j.peptides.2017.12.022. Epub 2017 Dec 27.
6
Design and synthesis of peptidic partial agonists of human neuromedin U receptor 1 with enhanced serum stability.设计并合成人神经肽 U 受体 1 的肽类部分激动剂,提高血清稳定性。
Bioorg Med Chem Lett. 2020 Sep 15;30(18):127436. doi: 10.1016/j.bmcl.2020.127436. Epub 2020 Jul 25.
7
Neuromedins NMU and NMS: An Updated Overview of Their Functions.神经调节素 NMU 和 NMS:功能的最新概述。
Front Endocrinol (Lausanne). 2021 Jul 1;12:713961. doi: 10.3389/fendo.2021.713961. eCollection 2021.
8
Cloning and expression patterns of neuromedin U and its receptors in pigs.猪的神经调节素 U 及其受体的克隆与表达模式。
Neuropeptides. 2017 Aug;64:47-60. doi: 10.1016/j.npep.2017.04.003. Epub 2017 Apr 6.
9
Discovery of a Pentapeptide Antagonist to Human Neuromedin U Receptor 1.人神经介素U受体1五肽拮抗剂的发现。
ACS Med Chem Lett. 2024 May 24;15(6):885-891. doi: 10.1021/acsmedchemlett.4c00091. eCollection 2024 Jun 13.
10
Development of potent and proteolytically stable human neuromedin U receptor agonists.开发强效且蛋白水解稳定的人神经调节素 U 受体激动剂。
Eur J Med Chem. 2018 Jan 20;144:887-897. doi: 10.1016/j.ejmech.2017.12.035. Epub 2017 Dec 14.

引用本文的文献

1
Discovery of a Pentapeptide Antagonist to Human Neuromedin U Receptor 1.人神经介素U受体1五肽拮抗剂的发现。
ACS Med Chem Lett. 2024 May 24;15(6):885-891. doi: 10.1021/acsmedchemlett.4c00091. eCollection 2024 Jun 13.
2
Unanticipated Characteristics of a Selective, Potent Neuromedin-U Receptor 2 Agonist.一种选择性、强效神经介素U受体2激动剂的意外特性。
ACS Bio Med Chem Au. 2022 May 27;2(4):370-375. doi: 10.1021/acsbiomedchemau.2c00016. eCollection 2022 Aug 17.
3
Effect of neuromedin U on allergic airway inflammation in an asthma model.神经介素U对哮喘模型中过敏性气道炎症的影响。
Exp Ther Med. 2020 Feb;19(2):809-816. doi: 10.3892/etm.2019.8283. Epub 2019 Dec 4.
4
Differential effects of selective agonists of neuromedin U1 and U2 receptors in obese and diabetic mice.神经肽 U1 和 U2 受体选择性激动剂在肥胖和糖尿病小鼠中的差异作用。
Br J Pharmacol. 2018 Jan;175(2):359-373. doi: 10.1111/bph.14077. Epub 2017 Dec 18.

本文引用的文献

1
Discovery of selective hexapeptide agonists to human neuromedin U receptors types 1 and 2.发现选择性六肽激动剂对人类孤啡肽 U 受体 1 型和 2 型。
J Med Chem. 2014 Aug 14;57(15):6583-93. doi: 10.1021/jm500599s. Epub 2014 Jul 18.
2
Development of a neuromedin U-human serum albumin conjugate as a long-acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptide.神经调节素 U-人血清白蛋白缀合物的开发作为肥胖和糖尿病治疗的长效候选药物。与聚乙二醇化肽的比较。
J Pept Sci. 2014 Jan;20(1):7-19. doi: 10.1002/psc.2582. Epub 2013 Nov 13.
3
PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetes.神经调节素 U 的聚乙二醇化产生了一种有前途的肥胖和糖尿病治疗候选药物。
Bioorg Med Chem. 2012 Aug 1;20(15):4751-9. doi: 10.1016/j.bmc.2012.06.003. Epub 2012 Jun 9.
4
Effects of peripherally administered neuromedin U on energy and glucose homeostasis.外周给予神经调节素 U 对能量和葡萄糖稳态的影响。
Endocrinology. 2011 Jul;152(7):2644-54. doi: 10.1210/en.2010-1463. Epub 2011 May 17.
5
Serum stabilities of short tryptophan- and arginine-rich antimicrobial peptide analogs.短色氨酸和精氨酸丰富的抗菌肽类似物的血清稳定性。
PLoS One. 2010 Sep 10;5(9):e12684. doi: 10.1371/journal.pone.0012684.
6
Neuromedin s is a novel anorexigenic hormone.神经介素S是一种新型的厌食激素。
Endocrinology. 2005 Oct;146(10):4217-23. doi: 10.1210/en.2005-0107. Epub 2005 Jun 23.
7
Identification of neuromedin S and its possible role in the mammalian circadian oscillator system.神经介素S的鉴定及其在哺乳动物昼夜节律振荡器系统中的可能作用。
EMBO J. 2005 Jan 26;24(2):325-35. doi: 10.1038/sj.emboj.7600526. Epub 2005 Jan 6.
8
Central actions of neuromedin U via corticotropin-releasing hormone.神经介素U通过促肾上腺皮质激素释放激素的中枢作用。
Biochem Biophys Res Commun. 2003 Nov 28;311(4):954-8. doi: 10.1016/j.bbrc.2003.10.098.
9
Central effects of neuromedin U in the regulation of energy homeostasis.神经介素U在能量平衡调节中的中枢作用。
Biochem Biophys Res Commun. 2000 Oct 14;277(1):191-4. doi: 10.1006/bbrc.2000.3669.
10
Purification and identification of neuromedin U as an endogenous ligand for an orphan receptor GPR66 (FM3).神经介素U作为孤儿受体GPR66(FM3)内源性配体的纯化与鉴定
Biochem Biophys Res Commun. 2000 Sep 24;276(2):435-8. doi: 10.1006/bbrc.2000.3502.